Skip to main content

. 1983 Apr 2;286(6371):1107–1108. doi: 10.1136/bmj.286.6371.1107

Effect of verapamil on enzyme release after early intravenous administration in acute myocardial infarction: double blind randomised trial.

L Thuesen, J R Jørgensen, H J Kvistgaard, J A Sørensen, M Vaeth, E B Jensen, J J Jensen, L Hagerup

PMCID: PMC1547460 PMID: 6404344

1107

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Maroko P. R. Experimental infarction studies. Clin Invest Med. 1980;3(1-2):139–142. [PubMed] [Google Scholar]
Nayler W. G., Grau A., Slade A. A protective effect of verapamil on hypoxic heart muscle. Cardiovasc Res. 1976 Nov;10(6):650–662. doi: 10.1093/cvr/10.6.650. [DOI] [PubMed] [Google Scholar]
Norris R. M., Whitlock R. M., Barratt-Boyes C., Small C. W. Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction. Circulation. 1975 Apr;51(4):614–620. doi: 10.1161/01.cir.51.4.614. [DOI] [PubMed] [Google Scholar]
Smith H. J., Singh B. N., Nisbet H. D., Norris R. M. Effects of verapamil on infarct size following experimental coronary occlusion. Cardiovasc Res. 1975 Jul;9(4):569–578. doi: 10.1093/cvr/9.4.569. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES